Elliott Levy, M.D.
Former Senior Vice President of Global Development, Amgen
Dr. Elliott Levy is an accomplished biopharmaceutical executive with more than 20 years of global research and development expertise, including leading clinical strategy and development for multiple programs at all stages of development at global biopharmaceutical companies Amgen and Bristol Myers Squibb.
Elliott served as Senior Vice President and Head of Global Development and R&D Strategy and Operations at Amgen from 2014-2021. Prior to Amgen, he was a Senior Vice President at Bristol Myers Squibb, where he held various R&D positions of increasing responsibility during his 17-year tenure at the company. He currently serves on the Boards of Editas Medicine and NuCana plc, both public biotechnology companies.
Dr. Levy received his B.A. in History from Yale College and an M.D. from the Yale School of Medicine, where he also completed fellowship training in internal medicine, nephrology, and clinical research.